New Jersey S 1102: Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: S 1102

Sponsors: Cruz-Perez, Nilsa I.

View New Jersey S 1102 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.